DDInter1734 DDInter1180
A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. Tacrine has been discontinued for the United States market.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Tacrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Mechlorethamine
Tacrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Dicyclomine
Tacrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Doxylamine
Tacrine {u} may lead to a major life threatening interaction when taken with {v} Iohexol
Tacrine may cause a minor interaction that can limit clinical effects when taken with Mechlorethamine
Tacrine may cause a moderate interaction that could exacerbate diseases when taken with Dicyclomine
Tacrine may cause a moderate interaction that could exacerbate diseases when taken with Doxylamine
Tacrine may lead to a major life threatening interaction when taken with Iohexol